Vito Leanza, Alfio D’Agati, Gianluca Leanza, Carlo Pafumi*, Mayada Chammas, Antonio Carbonaro
Department of Surgery, University of Catania, Italy, American University of Beirut-Lebanon
*Corresponding Author: Carlo Pafumi, Department of Surgery, University of Catania, Italy, American University of Beirut-Lebanon, Tel: +39095743554; E-mail: email@example.com
Citation: Leanza V, D’ Agati A, Leanza G, Pafumi C, Chammas M, et al. (2017) Uterine Myxoid Leiomyosarcoma Associated with Multiple Myomata in a Fertile Woman: A Case Report. J Oncol Res Ther 2016: J115.
Received Date: 09 December, 2016; Accepted Date: 14 January, 2017; Published Date: 24 January, 2017
A 37 year old woman (G1P1 spontaneous delivery) was admitted to our university hospital for menometrorrhagia. The case history showed the patient had menometrorrhagia for six months; moreover, during the abdominal examination we found a mass occupying the hypogastric and mesogastric area. The consistence was hard and the mass reached the level of the umbilicus. The combined vaginal-abdominal examination confirmed the presence of the mass on the anterior wall and, in addition, multiple myomata were felt; the uterus was found enlarged in size (equivalent to 18 pregnancy weeks); both ovaries and Fallopian tubes were regular. During surgery multiple myomata were visualized. The largest, 10 centimeter diameter, was soft in consistence with a gelatinous structure. Total abdominal hysterectomy with preservation of adnexa was performed.
Histopathological result gave evidence of myxoid leiomyosarcoma for the largest myoma, whereas the other nodes were benign.
Keywords: Myoma; Myomata; Myxoid Leiomyosarcoma; Uterus
The most common uterine mass during the fertile age are myomata [1,2]. The malignant degeneration of a myoma is a rare event.
Uterine sarcomas account for 3% of uterine cancers. Uterine sarcomas comprise leiomyosarcoma, endometrial stromal sarcoma, adenosarcoma, and their variants . The rarity of these tumors has prevented the performance of large epidemiological studies to identify risk factors. Data regarding parity, onset of menarche, or age at menopause as risk factors are inconclusive .
Myxoid Leiomyosarcoma (MLMSs) is an unusual tumor, in most cases recognized only after surgery. Rubin at al reported 18 cases of soft tissue Leiomyosarcomata in which myxoid stroma occupied >50% of the tissue examined. In their study patients ranged from 22 to 84 years old (median, 57.5 yrs) and female patients outnumbered male patients for 14 to 4 .
When MLMSs is associated with multiple myomata, the gross appearance of the malignant mass differs from others for a soft, necrotic and gelatinous aspect. In the past, the presence of 10 or more mitoses per 10 High-Power Fields (HPFs) was considered right key to establish the diagnosis of leiomyosarcoma. Even though mitotic index is an important feature in the assessment of malignancy, several studies based on large series of Uterine Smooth Muscle Tumors (U-SMTs) have shown that mitotic activity alone is not predictive of poor outcome [6-8]. Current criteria for diagnosis of classic leiomyosarcoma as require assessment of the number of Mitotic Figures (MFs) ⁄ 10 HPFs, nuclear atypia, and Tumor Cell Necrosis (TCN), in recognition of the fact that a variety of exogenous and endogenous hormones can influence both the mitotic index and the development of TCN .
With ultrasound examination topographic limits are normal, whereas the internal structure is inhomogeneous and hypoechogic compared to either the fibroid node or uterine wall.
The doppler flow shows that intra tumoral Resistance Index (RI) is significantly lower for uterine sarcomas comparison with leiomyomata, even though the result is not concordant in all cases. When a cut-off value of 0.5 for the RI is considered, the detection rate for uterine malignant mass is 67% .
In this study we report a case of uterine myxoid leiomyosarcoma associated with multiple myomata in a fertile woman.
A 37 year old female, gravida 1, para 1 (spontaneous delivery), was admitted to our university hospital complaining of a medical history of abdominal and pelvic pain, associated with menometrorrhagia lasting for 6 months. During this period the patient had been undergoing intensive therapy with iron drugs and folates.
At the admission blood tests showed: haemoglobin 11.5 g/dl; iron 31 µg/dl; Red Blood Cells 4.320.000/µL; White Blood Cells 7.900/µL; Platelets 285.000/µL.
Upon abdominal examination a mass occupying the hypogastric and mesogastric was felt. The consistence was hard and it reached the level of the umbilicus. On vaginal examination, uterus was 18 weeks size and a mass was palpated on the anterior wall, multiple myomata were felt as well, both ovaries and Fallopian tubes were regular.
Speculum examination showed a regular cervix and vagina with clots coming from the uterine orifice. With ultrasound examination uterus appeared increased in size (longitudinal: 180 mm; transversal: 107 mm; sagittal diameter: 108 mm). Four fibroid masses were detected, three were subserous myomata belonging to the right (42 mm) and the left (34 mm) angle of the uterus, and the third (59 mm) to the left uterine wall. The fourth and greatest mass (100 mm), localized on the fundus, was irregular in structure and inhomogeneous.
The Doppler flow study showed that the vascularization of the sick tissue was spread everywhere, mainly inside the tumor; on the contrary, the remaining three myomata showed a predominant peripheral vascularization. Resistance Index was regular for all the masses (RI: 0.8). The ultrasound aspect of the largest mass was hypoechoic compared with the fibroid nodes. The “Pfannestiel” Transversal laparotomy under general anesthesia was performed.
During surgery, as previously observed at ultra sonographic examination, uterus was found increased in size and multiple myomata were detected. The largest myoma had a grayish color and a gelatinous consistence; whereas the smaller ones were whitish and hard. Adnexa were regular in size and shape. Total hysterectomy with preservation of ovaries and Fallopian tubes was carried out. Post-operative course was uneventful. No transfusions were requested. After four days the patient was discharged.
The histopathological result found a malignant neoplasm (Myxoid Leiomyosarcoma ) infiltrating the surrounding myometrium; besides, areas of cotyleidoned leiomyoma were observed. The other fibroid nodes were typical for myomata. Endometrium was proliferative. A micro polypoid cervicitis was observed too.
The limit between benign and malignant tumors is not always defined. Even benign nodes can be associated with malignant ones. Histologically many types of leiomyomata have been recognized, although the aspect is not always indicative macroscopically. The great cellularity of myomata may lead to confusion with leiomyosarcomata.
Among various subtypes, the following are considered :
Uterine smooth muscle tumors range from the very common benign leiomyoma to the uncommon, but frequently lethal, leiomyosarcoma .
Usually, uterine smooth muscle neoplasms with fewer than 5 mitoses/10 high power fields are considered benign, whereas those with greater than 10 mitoses/10 high power field will often pursue a malignant course . Other leiomyosarcomatous changes occur as the myoma outgrows its blood supply and are termed hyaline, myxomatous, calcific, cystic, fatty, carneous (red), and sarcomatous. The mildest change is hyaline degeneration, found in 65% of myomas. Its appearance is homogeneous, with loss of the whorled pattern and cellular detail as the smooth muscle cells are replaced by fibrous connective tissue. Myxomatous change occurs in 15% of tumors, and calcific degeneration occurs in 4% to 10%, more commonly in older women. Cystic degeneration is found in 4% of leiomyomata and results from coalescence of hyalinised areas with liquefaction.
Fatty degeneration occurs rarely, but may result from late stage hyaline degeneration.
Immuno histochemical examination of p53, p16 and Ki-67 is considered a very useful tool for identification of malignant focus . Patients with a leiomyosarcoma with a leiomyomata component usually have favorable prognosis.
This case report offers to consider mainly two aspects related to the diagnosis and the treatment. Regarding diagnosis, we have to consider three stages: the pre-operative, the intra-operative and the final result. Pre-operative clinical diagnosis is difficult to perform and vaginal bimanual examination cannot disclose the malignancy of the mass.
Ultrasounds are useful for the diagnosis of the mass, but in many cases the difference between leiomyoma with benign degeneration and leiomyosarcoma is very tricky.
Doppler flowmetry is helpful when there is a suspicion of malignancy; moreover, in many cases it is not discriminating Intra-operatively, the macroscopic appearance of gelatinous aspect and its infiltrating characteristic tend towards malignancy.
The surgical treatment of gynecological masses complains both laparoscopic  and laparotomic approaches. Usually laparoscopy is preferred when masses are supposed benign or in some cases to define the diagnosis. In case of malignancy laparotomy is preferred.
Histologic result is considered the final diagnosis; nevertheless, in such a case the doubts remain and it confirms the old phrase: “natura non facit saltus” (nature doesn’t make steps), meaning that changes are gradual and limits are sometimes difficult to find.
This case report is very interesting due to the rarity of this pathology occuring in women of fertile age. Uterine MLMSs are often difficult to recognize, owing to their mild cytologic atypia and a low mitotic index.
When many nodes are discovered and alterations of aspect found, the malignancy must be suspected and a surgical treatment must be performed. A correct diagnosis and treatment may save the woman and lead to a favorable prognosis and good quality of life.
These results suggest that the intra tumoral RI detected by color and pulsed doppler ultrasonography by themselves could be poor for the preoperative differential diagnosis of uterine sarcoma.
Valentina Pafumi has carried out English language editing for this article.
Figure 1: Myxoid Leiomyosarcoma
Citation: Leanza V, D’ Agati A, Leanza G, Pafumi C, Chammas M, et al. (2017) Uterine Myxoid Leiomyosarcoma Associated with Multiple Myomata in a Fertile Woman: A Case Report. J Oncol Res Ther 2016: J115. DOI: 10.29011/2574-710X.000015